Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-20-003077
Filing Date
2020-01-07
Accepted
2020-01-07 16:48:11
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 d834396d424b3.htm 424B3 3009050
2 GRAPHIC g834396g02y88.jpg GRAPHIC 47346
3 GRAPHIC g834396g03e54.jpg GRAPHIC 41679
4 GRAPHIC g834396g03q96.jpg GRAPHIC 21353
5 GRAPHIC g834396g22t23.jpg GRAPHIC 27023
6 GRAPHIC g834396g78y38.jpg GRAPHIC 18324
  Complete submission text file 0001193125-20-003077.txt   3225156
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-235351 | Film No.: 20513728
SIC: 2834 Pharmaceutical Preparations